FDA OKs Novel Levodopa-Based Regimen for Parkinson’s ...Middle East

Medscape - News
Vyalev (AbbVie) is the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy to address motor fluctuations in advanced Parkinson’s disease. Medscape Medical News

Hence then, the article about fda oks novel levodopa based regimen for parkinson s was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA OKs Novel Levodopa-Based Regimen for Parkinson’s )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News